Cooper Companies (COO) Revenue & Revenue Breakdown
Cooper Companies Revenue Highlights
Latest Revenue (Y)
$3.59B
Latest Revenue (Q)
$1.00B
Main Segment (Y)
Coopervision Segment
Main Geography (Y)
UNITED STATES
Cooper Companies Revenue by Period
Cooper Companies Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-10-31 | $3.59B | 8.61% |
2022-10-31 | $3.31B | 13.20% |
2021-10-31 | $2.92B | 20.22% |
2020-10-31 | $2.43B | -8.39% |
2019-10-31 | $2.65B | 4.76% |
2018-10-31 | $2.53B | 18.41% |
2017-10-31 | $2.14B | 8.75% |
2016-10-31 | $1.97B | 9.45% |
2015-10-31 | $1.80B | 4.62% |
2014-10-31 | $1.72B | 8.19% |
2013-10-31 | $1.59B | 9.87% |
2012-10-31 | $1.45B | 8.59% |
2011-10-31 | $1.33B | 14.87% |
2010-10-31 | $1.16B | 7.23% |
2009-10-31 | $1.08B | 1.62% |
2008-10-31 | $1.06B | 11.84% |
2007-10-31 | $950.64M | 10.67% |
2006-10-31 | $858.96M | 6.49% |
2005-10-31 | $806.62M | 64.56% |
2004-10-31 | $490.18M | 19.04% |
2003-10-31 | $411.79M | 30.60% |
2002-10-31 | $315.31M | 34.42% |
2001-10-31 | $234.57M | 18.88% |
2000-10-31 | $197.32M | 19.37% |
1999-10-31 | $165.30M | 12.30% |
1998-10-31 | $147.20M | 4.03% |
1997-10-31 | $141.50M | 29.70% |
1996-10-31 | $109.10M | 12.36% |
1995-10-31 | $97.10M | 1.57% |
1994-10-31 | $95.60M | 3.13% |
1993-10-31 | $92.70M | - |
Cooper Companies Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-07-31 | $1.00B | 6.39% |
2024-04-30 | $942.60M | 1.18% |
2024-01-31 | $931.60M | 0.49% |
2023-10-31 | $927.10M | -0.33% |
2023-07-31 | $930.20M | 6.02% |
2023-04-30 | $877.40M | 2.20% |
2023-01-31 | $858.50M | 1.23% |
2022-10-31 | $848.10M | 0.56% |
2022-07-31 | $843.40M | 1.64% |
2022-04-30 | $829.80M | 5.41% |
2022-01-31 | $787.20M | 3.70% |
2021-10-31 | $759.10M | -0.56% |
2021-07-31 | $763.40M | 6.10% |
2021-04-30 | $719.50M | 5.73% |
2021-01-31 | $680.50M | -0.16% |
2020-10-31 | $681.60M | 17.88% |
2020-07-31 | $578.20M | 10.15% |
2020-04-30 | $524.90M | -18.77% |
2020-01-31 | $646.20M | -6.56% |
2019-10-31 | $691.60M | 1.80% |
2019-07-31 | $679.40M | 3.84% |
2019-04-30 | $654.30M | 4.17% |
2019-01-31 | $628.10M | -3.59% |
2018-10-31 | $651.50M | -1.29% |
2018-07-31 | $660.00M | 4.55% |
2018-04-30 | $631.30M | 7.00% |
2018-01-31 | $590.00M | 5.08% |
2017-10-31 | $561.50M | 0.99% |
2017-07-31 | $556.00M | 6.43% |
2017-04-30 | $522.40M | 4.67% |
2017-01-31 | $499.10M | -3.77% |
2016-10-31 | $518.65M | 0.76% |
2016-07-31 | $514.73M | 6.39% |
2016-04-30 | $483.79M | 7.60% |
2016-01-31 | $449.64M | -1.29% |
2015-10-31 | $455.54M | -1.33% |
2015-07-31 | $461.68M | 6.21% |
2015-04-30 | $434.68M | -2.36% |
2015-01-31 | $445.17M | -4.88% |
2014-10-31 | $468.00M | 8.21% |
2014-07-31 | $432.48M | 4.89% |
2014-04-30 | $412.32M | 1.81% |
2014-01-31 | $404.98M | -1.67% |
2013-10-31 | $411.85M | -0.03% |
2013-07-31 | $411.99M | 7.28% |
2013-04-30 | $384.04M | 1.11% |
2013-01-31 | $379.84M | -4.15% |
2012-10-31 | $396.30M | 4.79% |
2012-07-31 | $378.19M | 9.75% |
2012-04-30 | $344.59M | 5.68% |
2012-01-31 | $326.06M | -9.66% |
2011-10-31 | $360.91M | 2.71% |
2011-07-31 | $351.40M | 8.02% |
2011-04-30 | $325.30M | 10.94% |
2011-01-31 | $293.23M | -6.42% |
2010-10-31 | $313.35M | 5.99% |
2010-07-31 | $295.63M | 2.20% |
2010-04-30 | $289.27M | 11.15% |
2010-01-31 | $260.26M | -8.18% |
2009-10-31 | $283.45M | -0.62% |
2009-07-31 | $285.23M | 9.45% |
2009-04-30 | $260.59M | 3.76% |
2009-01-31 | $251.14M | -6.57% |
2008-10-31 | $268.81M | -5.97% |
2008-07-31 | $285.88M | 8.52% |
2008-04-30 | $263.45M | 7.52% |
2008-01-31 | $245.03M | - |
Cooper Companies Revenue Breakdown
Cooper Companies Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Oct 23 | Oct 22 | Oct 21 | Oct 20 | Oct 19 |
---|---|---|---|---|---|
Coopersurgical Segment | $1.17B | $633.60M | $451.30M | $358.80M | $680.50M |
Coopervision Segment | $2.42B | $737.40M | $697.50M | $598.20M | $1.97B |
CooperVision Segment | $2.42B | - | - | - | - |
CooperSurgical Segment | $1.17B | - | - | - | - |
Quarterly Revenue by Product
Product/Service | Jul 24 | Apr 24 | Jan 24 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coopervision Segment | $675.60M | $635.90M | $621.50M | $1.26B | $1.18B | $581.30M | $561.80M | $566.30M | $553.80M | $561.50M | $564.90M | $557.50M | $522.60M | $507.00M | $506.30M | $449.30M | $402.20M | $485.20M | $509.60M | $509.10M |
Coopersurgical Segment | $327.20M | $306.70M | $310.10M | $600.00M | $576.20M | $277.20M | $286.30M | $277.10M | $276.00M | $225.70M | $194.20M | $205.90M | $196.90M | $173.50M | $175.30M | $128.90M | $122.70M | $161.00M | $182.00M | $170.30M |
Cooper Companies Revenue Breakdown by Country
Annual Revenue by Country
Country | Oct 23 | Oct 22 | Oct 21 | Oct 20 | Oct 18 |
---|---|---|---|---|---|
Rest Of The World | $739.80M | $682.70M | $625.40M | $537.50M | - |
Europe | $2.06B | $987.20M | $957.90M | $789.80M | $1.25B |
UNITED STATES | $2.38B | $1.64B | $1.34B | $1.10B | $1.44B |
Quarterly Revenue by Country
Country | Jul 24 | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UNITED STATES | $511.20M | $479.00M | $470.40M | $1.03B | $462.50M | $443.10M | $434.80M | $436.40M | $418.00M | $418.90M | $365.30M | $346.30M | $343.70M | $336.10M | $313.10M | $324.00M | $263.70M | $222.50M | $293.50M | $971.40M |
Europe | $297.00M | $276.70M | $276.60M | $1.28B | $279.70M | $249.50M | $248.20M | $237.30M | $256.30M | $243.20M | $250.40M | $248.40M | $258.70M | $230.00M | $220.80M | $212.50M | $185.20M | $178.80M | $213.40M | $513.60M |
Rest Of World, Excluding United States And Europe | - | - | $184.60M | $188.00M | $184.80M | $175.50M | $169.10M | $167.70M | $171.50M | $161.00M | $153.40M | $146.60M | $129.30M | $123.70M | $139.30M | - | - | - | - | - |
Coopervision Segment | - | - | - | - | - | - | $581.30M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Coopersurgical Segment | - | - | - | - | - | - | $277.20M | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cooper Companies Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BDX | Becton, Dickinson and Company | $19.37B | $4.99B |
RMD | ResMed | $4.69B | $1.22B |
BLCO | Bausch + Lomb | $4.15B | $1.20B |
HOLX | Hologic | $4.03B | $1.01B |
COO | Cooper Companies | $3.59B | $1.00B |
ATR | AptarGroup | $3.49B | $909.29M |
TFX | Teleflex | $2.97B | $764.38M |
WST | West Pharmaceutical Services | $2.95B | $746.90M |
NVST | Envista | $2.57B | $884.70M |
ICUI | ICU Medical | $2.26B | $596.46M |
HAE | Haemonetics | $1.31B | $336.17M |
MMSI | Merit Medical Systems | $1.26B | $339.85M |
RGEN | Repligen | $638.76M | $154.07M |
ANGO | AngioDynamics | $303.91M | $67.49M |
COO Revenue FAQ
What is Cooper Companies’s yearly revenue?
Cooper Companies's yearly revenue for 2023 was $3.59B, representing an increase of 8.61% compared to 2022. The company's yearly revenue for 2022 was $3.31B, representing an increase of 13.20% compared to 2021. COO's yearly revenue for 2021 was $2.92B, representing an increase of 20.22% compared to 2020.
What is Cooper Companies’s quarterly revenue?
Cooper Companies's quarterly revenue for Q3 2024 was $1B, a 6.39% increase from the previous quarter (Q2 2024), and a 7.80% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $942.6M, a 1.18% increase from the previous quarter (Q1 2024), and a 7.43% increase year-over-year (Q2 2023). COO's quarterly revenue for Q1 2024 was $931.6M, a 0.49% increase from the previous quarter (Q4 2023), and a 8.51% increase year-over-year (Q1 2023).
What is Cooper Companies’s revenue growth rate?
Cooper Companies's revenue growth rate for the last 3 years (2021-2023) was 22.95%, and for the last 5 years (2019-2023) was 35.42%.
What are Cooper Companies’s revenue streams?
Cooper Companies's revenue streams in t 23 are Coopersurgical Segment, Coopervision Segment, CooperVision Segment, and CooperSurgical Segment. Coopersurgical Segment generated $1.17B in revenue, accounting 16.27% of the company's total revenue, up 84.58% year-over-year. Coopervision Segment generated $2.42B in revenue, accounting 33.73% of the company's total revenue, up 228.68% year-over-year. CooperVision Segment generated $2.42B in revenue, accounting 33.73% of the company's total revenue CooperSurgical Segment generated $1.17B in revenue, accounting 16.27% of the company's total revenue
What is Cooper Companies’s main source of revenue?
For the fiscal year ending Oct 23, the largest source of revenue of Cooper Companies was Coopervision Segment. This segment made a revenue of $2.42B, representing 33.73% of the company's total revenue.